 - Heshe had allergy or hypersensitivity to oxycodone or other ingredients in the formulations or had received monoamineoxidase, CYP3A cytochrome P450 3A enzymes or CYP2D6 cytochrome P450 2D6 enzyme inhibitors during the previous month or other reason that was considered to contraindicate participation. 